Similarly, the 180-day cumulative incidence of grade II–IV acute GVHD was 19% in patients with day 14 IL-7 levels>median (5.2 pg/mL) versus 37% in patients with day 14 IL-7 levels ≤ median (P = 0.18) (Figure 3B). The gene discussed is IL7; the disease is acute graft versus host disease.